Cell Therapeutics Holding Its Own (CTIC)

Posted in pre-market 
April 12th, 2010

Cell Therapeutics Inc. (NASDAQ: CTIC) is trading higher this morning after its special meeting Friday ad after a corporate update.  Weekend chat rooms and online posts were of course still very mixed on this one with the bulls touting a definite approval down the road and the bears touting that it has little to nothing going for it.  The company still plans to file for expanded access for patients With relapsed or refractory aggressive Non-Hodgkin’s Lymphoma.

At 8:02 AM EST shares are up 4% at $0.65 on 120,000 shares.  With the millions of shares it trades each day, well be watching this penny stock.


Comments are closed